MIT experts applied Weyl's law to improve machine learning efficiency, cutting down on the training data needed for AI systems, as presented at a December 2023 conference.

A study at Massachusetts General Hospital uses Neuropixels probes to advance understanding of the brain's speech production, with implications for treating language disorders.

A study by MIT researchers revealed that doctors have more difficulty diagnosing diseases on darker skin, underscoring the need for better training and potential AI assistance.

An AI system from BIDMC and MIT may allow earlier detection of pancreatic cancer, increasing survival rates by identifying at-risk individuals 18 months prior to usual diagnosis.

Research from UMass Amherst shows that during COVID-19, hospitality firms that cut CEO pay rather than jobs gained loyalty from ethically minded customers, according to a study published in Cornell Hospitality Quarterly.

MIT astronomers have doubled the number of known tidal disruption events (TDEs) by observing 18 black holes eating stars using infrared data from NEOWISE.

A study reveals that climate change may have the most severe impact on the oldest African elephants, crucial for ecosystem balance and elephant populations.

MIT and Brigham and Women's Hospital researchers have developed a novel microscopy technique that provides unprecedented detail of brain tissue, potentially altering brain tumor diagnosis and treatment.

Biogen ends its controversial Alzheimer's drug Aduhelm due to efficacy doubts and commercial challenges, facing a $60 million cost and shifting focus to a newer treatment, Leqembi.

Draper unveiled a replica of Mars in their atrium, symbolizing their commitment to space exploration and partnership with NASA. The model precedes their museum's March reopening for public educational tours.

Boston Police seek public help to identify two individuals involved in a commercial burglary in Roxbury. The department has released surveillance images and encourages tips via CrimeStoppers for anonymity.

Vertex Pharmaceuticals' experimental painkiller, VX-548, shows potential to relieve acute pain effectively without addiction risks, outperforming opioids in clinical trials.

MIT and Ragon Institute researchers have developed a novel DNA-based vaccine that evokes a focused immune response and might be effective against viruses like HIV and SARS-CoV-2.